pt141 half life Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction PT-141 (Bremelanotide) | Eon Peptides
Description
Oral administration and intralesional injection of hyaluronic acid versus intralesional injection alone in Peyronies disease: results from a phase III study
Creates a spiffy lookclearly
A logistic regression analysis of risk factors in ME/CFS pathogenesis
Many women feel guilty or blame themselves
Why the skin stops producing melanin is still not 100% certain, but it's thought to be due to extended sun exposure
